HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Hydrops of gallbladder — Clinical Guidelines

Overview

Non-immune hydrops fetalis (NIHF) is characterized by the accumulation of fluid in two or more fetal compartments, excluding those due to red cell alloimmunization, posing significant risks to fetal survival 4. It encompasses a broad spectrum of etiologies including cardiovascular, chromosomal, hematologic abnormalities, structural anomalies, placental issues, and rare conditions like placental chorioangioma and intussusception 5 10.

Diagnosis

Key Diagnostic Criteria: Presence of fluid accumulation in ≥2 fetal compartments (pleural, peritoneal, pericardial, subcutaneous) 4.

Recommended Tests:

- Detailed ultrasound examination to identify structural anomalies and assess fluid distribution 3. - Genetic testing for chromosomal abnormalities and monogenic disorders 1 8. - Maternal antibody screening (e.g., anti-Jra antibodies) 2. - Fetal echocardiography to evaluate cardiac function 4.

Grading: Severity grading based on clinical presentation and associated anomalies 3.

Management

First-Line Treatments:

- Address underlying etiology if identifiable (e.g., surgical intervention for intussusception 10). - Supportive care including close monitoring and management of complications 7.

Adjunctive Treatments:

- Specific treatments depend on identified cause (e.g., Kasabach-Merritt syndrome management with platelet transfusions 9). - In cases of suspected maternal syndrome, manage maternal condition to mitigate fetal impact 12.

Special Populations

Pregnancy:

- Monitor closely for signs of preeclampsia, polyhydramnios, and premature labor 15. - Consider genetic counseling due to recurrent cases 6.

Pediatrics: Postnatal management focuses on treating underlying causes and supportive care for neonates born with hydrops 7 9.

Key Recommendations

Perform comprehensive genetic and imaging evaluations to identify treatable causes of non-immune hydrops fetalis (Evidence: Strong 1 3 4).

Initiate urgent and specific treatments based on identified etiologies, such as surgical interventions for intussusception or hematologic support for Kasabach-Merritt syndrome (Evidence: Moderate 10 9).

Offer genetic counseling in cases of recurrent non-immune hydrops fetalis to families (Evidence: Expert opinion 6).

Closely monitor pregnancies complicated by non-immune hydrops fetalis for maternal conditions like preeclampsia and manage accordingly (Evidence: Moderate 15).

References

1 Quinn AM, Valcarcel BN, Makhamreh MM, Al-Kouatly HB, Berger SI. A systematic review of monogenic etiologies of nonimmune hydrops fetalis. Genetics in medicine : official journal of the American College of Medical Genetics 2021. link 2 Tanaka K, Hosoi K, Yoshiike S, Nagahama K, Tanigaki S, Shibahara J et al.. Mirror syndrome due to anti-Jra alloimmunization. Taiwanese journal of obstetrics & gynecology 2020. link 3 Désilets V, De Bie I, Audibert F. No. 363-Investigation and Management of Non-immune Fetal Hydrops. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2018. link 4 Norton ME, Chauhan SP, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. American journal of obstetrics and gynecology 2015. link 5 Sivasli E, Tekşam O, Haliloğlu M, Güçer S, Orhan D, Gürgey A et al.. Hydrops fetalis associated with chorioangioma and thrombosis of umbilical vein. The Turkish journal of pediatrics 2009. link 6 Abboy S, Weaver DD, Padilla LM, Faught P, Akin KK. Recurrent non-immune hydrops fetalis with gracile bones and dysmorphic features in siblings. American journal of medical genetics. Part A 2008. link 7 Smoleniec J, James D. Non-immune hydrops. The importance of urgent investigation if the prognosis is to be improved. West of England medical journal 1991. link 8 Rosen RS, Bocian ME. Hydrops fetalis in the McKusick-Kaufman syndrome: a case report. American journal of obstetrics and gynecology 1991. link90234-i) 9 Skopec LL, Lakatua DJ. Non-immune fetal hydrops with hepatic hemangioendothelioma and Kasabach-Merritt syndrome: a case report. Pediatric pathology 1989. link 10 Brinson RA, Goldsmith JP. Nonimmune hydrops fetalis associated with intrauterine intussusception. Journal of perinatology : official journal of the California Perinatal Association 1988. link 11 Kirkinen P, Jouppila P, Leisti J. Transient fetal ascites and hydrops with a favorable outcome. A report of two cases. The Journal of reproductive medicine 1987. link 12 Mahmood TA. A reappraisal of the maternal syndrome associated with hydrops fetalis. European journal of obstetrics, gynecology, and reproductive biology 1987. link90120-1) 13 Bryan EM, Nicholson E. Hydrops fetalis in South Korea. Annals of tropical paediatrics 1981. link 14 Rees L, Vlies PR, Adams J. Hydrops fetalis, an unusual cause, presentation and method of diagnosis. Case report. British journal of obstetrics and gynaecology 1980. link 15 Cumming DC. Recurrent nonimmune hydrops fetalis. Obstetrics and gynecology 1979. link

Hydrops of gallbladder